Poslední aktualizace :
29/10/2024
rakovina drog   Epirubicin hydrochloride  
injekce
Stabilita roztoků Stabilita směsí Faktory ovlivňující stabilitu Kompatibilita Způsoby aplikace Odkazy pdf
   Chemický vzorec  

Obchodní název   Obchodní název     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Anthracine Malajsie
Axirubicine NÏmecko
Bendaepi NÏmecko
Binarin Mexiko
Bioepycina Polsko
Crisabon Argentina
Cuatroepi Argentina
Ecclepia Rumunsko
Elebicin Mexiko
Ellence USA
Epi Cell NÏmecko
Epidoxo Argentina, Chile, Venezuela
Epifil Ekvádor
Epilem Kolumbie, Mexiko
Epimedac NÏmecko
Epirubicin Austrálie, Belgie, Dánsko, Island, MaÔarsko, nový Zéland, Rakousko, Saúdská Arábie, Švédsko, Švýcarsko, Turecko, Velká Británie
Epirubicina äpanÏlsko, Argentina, Ekvádor, Kolumbie, Mexiko, Rumunsko
Epirubicine Belgie, Francie, Švýcarsko
Farmarubicin Turecko
Farmorubicin BrazÌlie, Dánsko, Finsko, Norsko, Rakousko, Saúdská Arábie, Švédsko, Švýcarsko, ÿecko
Farmorubicin CSV Jihoafrická republika
Farmorubicin PFS Chorvatsko, Polsko, Slovinsko
Farmorubicin RD BrazÌlie, Polsko, rusky, Švýcarsko
Farmorubicin RTU Nizozemsko
Farmorubicina äpanÏlsko, BrazÌlie, Itálie, Portugalsko
Farmorubicine Belgie, Francie
Pharmorubicin Velká Británie
Odkazy   injekce   Odkazy : Epirubicin hydrochloride  
typ uveřejnění
148 noviny Dine T, Cazin JC, Gressier B, Luycks M, Brunet C, Cazin M, Goudaliez F, Mallevais ML, Toraub I.
Stability and compatibility of four anthracyclines: doxorubicin, epirubicin, daunorubicin and pirarubicin with PVC infusion bags.
Pharm Weekbl [Sci] 1992 ; 14: 365-369.
525 noviny De Vroe C, De Muynck C, Remon JP, Samsom M.
A study on the stability of three antineoplastic drugs and on their sorption by IV delivery systems and end-line filters.
Int J Pharm 1990 ; 65: 49-56.
683 noviny Walker SE, Lau DWC, DeAngelis C, Iazetta J, Coons C.
Epirubicin stability in syringes and glass vials and evaluation of chemical contamination.
Can J Hosp Pharm 1990 ; 43: 265-272.
686 noviny Wood MJ, Irwin WJ, Scott DK.
Stability of doxorubicin, daunorubicin and epirubicin in plastic syringes and minibags.
J Clin Pharm Ther 1990 ; 15: 279-289.
887 noviny Pujol M, Munoz M, Prat J, Giona V, De Bolos J.
Stability study of epirubicin in NaCl 0.9% injection.
Ann Pharmacotherapy 1997 ; 31: 992-995.
1237 noviny Keusters L, Stolk LML, Umans R, Van Asten P.
Stability of solutions of doxorubicin and epirubicin in plastic minibags for intravesical use after storage at -20°C and thawing by microwave radiation.
Pharm Weekbl [Sci] 1986 ; 8: 194-197.
1265 noviny Wood MJ, Irwin WJ, Scott DK.
Photodegradation of doxorubicin, daunorubicin and epirubicin measured by high-performance liquid chromatography.
J Clin Pharm Ther 1990 ; 15: 291-300.
1317 noviny Adams PS, Haines-Hutt RF, Bradford E, Palmer A, Rowland CG.
Pharmaceutical aspects of home infusion therapy for cancer patients.
Pharm J 1987 ; 238: 476-478.
1662 noviny Trissel LA, Saenz CA, Ingram DS, Ogundele AB.
Compatibility screening of oxaliplatin during simulated Y-site administration with other drugs.
J Oncol Pharm Practice 2002 ; 8: 33-37.
1823 noviny Sewell GJ, Rigby-Jones AE, Priston MJ.
Stability of intravesical epirubicin infusion: a sequential temperature study.
J Clin Pharm Ther 2003 ; 28: 349-353.
1897 noviny Sautou-Miranda V, Brigas F, Thibault M, Chopineau J.
Compatibility of doxorubicin, daunorubicin and epirubicin with low-density polyethylene and polyvinyl chloride, and stability in various conditions of storage.
EJHP 2001 ; 7, 3: 108-115.
1955 noviny Trissel LA, Zhang Y.
Palonosetron HCl compatibility and stability with doxorubicin HCl and epirubicin HCl during simulated Y-site administration.
Ann Pharmacotherapy 2005 ; 39: 280-283.
2168 noviny Ozdemir FA, Anilanmert B, Pekin M.
Spectrophotometric investigation of the chemical compatibility of the anticancer irinotecan-HCl and epirubicin-HCl in the same infusion solution.
Cancer Chemother Pharmacol 2005 ; 56, 5: 529-534.
2257 Laboratoř Stability of epirubicin "Ebewe" infusion solutions.
Ebewe Pharma 2007
3473 noviny Bennis Y, Savry A, Correard F, Montana M, Sauzet C, Gauthier-Villano L, Pisano P, Pourroy B.
Stability of a highly concentrated solution of epirubicin for conventional transcatheter arterial chemoembolization.
Int J Pharm 2015 ; 495, 2: 956-962.
3474 Laboratoř Fluorouracil - Summary of Product Characteristics
Accord Healthcare Limited 2009
3632 Laboratoř Epirubicine (Epirubicine Hospira®) - Summary of Product Characteristics
Hospira 2017
3670 noviny Sewell G, Massimini M.
Studies on the stability and compatibility of cytotoxic drug infusion with the Tevadaptor system.
EJOP 2014 ; 8, 3: 26-30.
3708 plakát Sarakbi I, Thiesen J, Krämer I.
Compatibility of epirubicin-loaded DC Beads with different contrast media.
ECOP 2 Krakow 2014
3918 noviny Sarakbi I, Krämer I.
Compatibility of epirubicin-loaded DC bead™ with different non-ionic contrast media.
J Oncol Pharm Practice 2016 ; 22: 749-756.
4352 noviny Li J, Yao C, Xu Y, Ping P, Yin H, Sun Y.
In vitro compatibility and stability of admixtures containing etoposide, epirubicin hydrochloride and vindesine sulphate in a single infusion bag.
J Clin Pharm Ther 2019 ; 44: 875-882.

  Mentions Légales